Category Archives: Corporate

Pfizer Wins Bidding War for Medivation; But Why Bother?

Pharmaceutical giant Pfizer Inc. (New York City) is paying $14 billion to buy Medivation Inc. (San Francisco), a biotech company that sells a high-priced prostate cancer medication discovered by UCLA, according to the… Read more »

Aetna Latest Insurer Pulling Back on Obamacare Plans

Aetna Inc. (Hartford CT) said it will reduce by more than 500 U.S. counties its participation in public exchanges under the Affordable Care Act in the face of hundreds of millions of… Read more »

Glaxo, Google Parent Create $715 Million Bioelectronic Medicines Venture

GlaxoSmithKline PLC (London) and Google parent Alphabet Inc. (Mountain View CA) have teamed up to develop what they call bioelectronic medicines, or treatments that use miniature implanted electronic devices to modify how electrical impulses are… Read more »

Valeant Plummets on Criminal Probe of Philidor Unit

Valeant Pharmaceuticals International Inc. (Laval Quebec) did an about-face and fell 11% on Thursday as new details about a criminal investigation into the drugmaker reignited investor concerns about the company’s… Read more »

Bristol-Myers’ Opdivo Fails in Key Lung-Cancer Study; Shares Plunge, as Do Patients’ Hopes

A cancer drug’s surprise failure in a clinical trial erased $20 billion from Bristol-Myers Squibb Co.’s (New York City) market value Friday, and raised serious questions about one of the industry’s… Read more »

UnitedHealth 2Q Profit Falls 51%, But Don’t be Misled by the Merger Mania and What UNH Stands to Gain

UnitedHealth Group Inc. (Minnetonka MN) posted strong earnings for its latest quarter as revenue continued to surge in its pharmacy-services business. The company, which is the biggest U.S. health insurer, also gave… Read more »

Biogen’s 2Q Profit Crushes Views; CEO to Depart

Biogen Inc. (Cambridge MA) stock jumped Thursday after the drugmaker reported strong sales of some of its newest treatments for multiple sclerosis and hemophilia. The company’s net income and sales… Read more »

Department of Justice Sues Anthem, Aetna to Block Insurer Mergers

Anthem Inc. (Indianapolis IN) said its proposed $48 billion merger with rival health insurer Cigna Corp. (Bloomfield CT) will lower consumer costs and extend coverage to more people, in response… Read more »

GlaxoSmithKline Taps Apple’s ResearchKit for Arthritis Study

GlaxoSmithKline PLC (London) has started a rheumatoid arthritis study using Apple Inc.’s (Cupertino CA) ResearchKit, marking the first time a drugmaker has used the health system for the iPhone to… Read more »